[Form 4] PFIZER INC Insider Trading Activity

LITTMAN DAN R. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

LITTMAN DAN R. reported acquisition or exercise transactions in this Form 4 filing.

Pfizer Inc. director Dan R. Littman received an award of 7,686.539 Phantom Stock Units on deferred compensation terms. Each unit represents one phantom share of Pfizer common stock and is tied to a reference price of $26.67 per unit.

After this grant, Littman holds a total of 74,533.568 Phantom Stock Units. The units represent deferred director compensation under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors and will be settled in cash or common stock, at his election, after he retires from the Board.

Insider Trade Summary

Grant/Award: 7,686.539 shares

Grant/Award 1 txn

Insider LITTMAN DAN R.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Units	7,686.539	$26.67	$205K

Holdings After Transaction: Phantom Stock Units — 74,533.568 contracts (Direct)

Footnotes (3)

1. F1. Each unit represents one phantom share of common stock.
2. F2. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.
3. F3. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Key Figures

Phantom Stock Units granted: 7,686.539 units Reference price per unit: $26.67 per unit Total Phantom Stock Units after grant: 74,533.568 units +1 more

4 metrics

Phantom Stock Units granted 7,686.539 units Director award on April 23, 2026

Reference price per unit $26.67 per unit Grant price for Phantom Stock Units

Total Phantom Stock Units after grant 74,533.568 units Holdings following reported transaction

Underlying common stock equivalence 7,686.539 shares Each unit represents one phantom share of common stock

Key Terms

Phantom Stock Units, Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors, deferred director's compensation, settled in cash or common stock

4 terms

Phantom Stock Units financial

"Each unit represents one phantom share of common stock."

Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.

Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors financial

"Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors."

deferred director's compensation financial

"These units represent deferred director's compensation that are settled in cash or common stock at the director's election."

settled in cash or common stock financial

"settled in cash or common stock at the director's election, following the reporting person's retirement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pfizer (PFE) disclose for director Dan R. Littman?

Pfizer reported that director Dan R. Littman received 7,686.539 Phantom Stock Units as a compensation award. These units are a form of deferred director pay, linked to Pfizer’s common stock value, and increase his total Phantom Stock Units to 74,533.568 after the transaction.

What are Phantom Stock Units in Pfizer (PFE)'s Form 4 filing?

Phantom Stock Units are bookkeeping units where each unit represents one phantom share of Pfizer common stock. They track the value of the stock but do not involve immediate share issuance, instead functioning as deferred compensation that can later be settled in cash or common stock.

How and when will Dan R. Littman’s Pfizer Phantom Stock Units be settled?

The Phantom Stock Units will be settled after Dan R. Littman retires from Pfizer’s Board of Directors. At that time, he may elect to receive the value of these units either in cash or in Pfizer common stock, according to the plan’s terms.

Does Pfizer’s reported Phantom Stock Unit grant involve open-market buying or selling of PFE shares?

No. The Form 4 shows a grant of 7,686.539 Phantom Stock Units as director compensation, not an open-market purchase or sale. The units are awarded under Pfizer’s deferred compensation and unit award plan rather than through trading Pfizer shares in the market.

What plan governs the Phantom Stock Units granted to Pfizer (PFE) director Dan R. Littman?

The Phantom Stock Units were granted under the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. This plan provides a way for outside directors to receive deferred compensation awards that track Pfizer’s common stock and settle after board service ends.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 06:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LITTMAN DAN R.

(Last) (First) (Middle)

66 HUDSON BOULEVARD EAST

ATTN: CORPORATE SECRETARY

(Street)

NEW YORK NEW YORK 10001-2192

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PFIZER INC [ PFE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Units	(1)	04/23/2026		A		7,686.539(2)		(3)	(3)	Common Stock	7,686.539	$26.67	74,533.568	D

Explanation of Responses:

1. Each unit represents one phantom share of common stock.

2. Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

3. These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

	/s/ Shanice A. Reid, by power of atty., for Dan R. Littman	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)